| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/06/2013 | EP2564706A1 Anthranilamide insecticides |
| 03/06/2013 | EP2563777A2 Inverse agonists and neutral antagonists for the tsh receptor |
| 03/06/2013 | EP2563773A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites |
| 03/06/2013 | EP2563772A1 Fungicide hydroximoyl-heterocycles derivatives |
| 03/06/2013 | EP2563771A2 Metalloenzyme inhibitor compounds |
| 03/06/2013 | EP2563127A1 Prolylcarboxypeptidase inhibitors |
| 03/06/2013 | EP2563124A1 Kappa opioid receptor binding ligands |
| 03/06/2013 | EP2563123A1 Novel beta 3 adrenergic receptor agonists |
| 03/06/2013 | CN102958928A Dimeric SMAC Mimetics |
| 03/06/2013 | CN102958927A Indazole inhibitors of kinase |
| 03/06/2013 | CN102958926A Rupatadine salt as an antihistaminic agent |
| 03/06/2013 | CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 03/06/2013 | CN102958919A Novel tetrahydroquinoline derivatives |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102958917A Compositions and methods for modulating the wnt signaling pathway |
| 03/06/2013 | CN102958915A Compound having carbazole ring structure, and organic electroluminescent device |
| 03/06/2013 | CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952120A Compound for electroluminescent device and organic electroluminescent devices using the same |
| 03/06/2013 | CN102952119A Sodium rabeprazole preparation method |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102952117A Preparation method of imidazole derivatives |
| 03/06/2013 | CN102952116A Double-centre nicotine ionic liquid, and preparation method and application thereof |
| 03/06/2013 | CN102952076A Preparation of pyrazoline compound and application of pyrazoline compound in anticancer treatment |
| 03/06/2013 | CN102952062A Substituted benzoheterocyclic compounds and preparation method and application thereof |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102225933B 2, 6-dimethyl-3, 5-bis[3-(5- trifluoromethyl)-1H- pyrazole] pyridine and synthesis method thereof |
| 03/06/2013 | CN102015627B Amide compounds, preparation methods and uses thereof |
| 03/06/2013 | CN101687842B Modulators of CFTR |
| 03/06/2013 | CN101679359B Quinolines and their therapeutic use |
| 03/06/2013 | CN101679273B 1-substituted tetrahydroisoquinoline compound |
| 03/06/2013 | CN101591330B Sertindole crystal form and preparation method thereof |
| 03/06/2013 | CN101584337B 1, 5-disubstituted hexahydro triazine pesticide and preparation method thereof |
| 03/06/2013 | CN101223157B Methods for synthesizing heterocyclic compounds |
| 03/06/2013 | CN101163693B Antibacterial piperidine derivatives |
| 03/05/2013 | USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder |
| 03/05/2013 | US8389733 Process for the preparation of (R,S)-nicotine |
| 03/05/2013 | US8389732 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
| 03/05/2013 | US8389731 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389720 Quinolone neuropeptide S receptor antagonists |
| 03/05/2013 | US8389718 Insecticidal triazines and pyrimidines |
| 03/05/2013 | US8389717 Modulators for amyloid beta |
| 03/05/2013 | US8389560 HCV protease inhibitors |
| 03/05/2013 | US8389543 Metalloenzyme inhibitor compounds |
| 03/05/2013 | US8389537 Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 03/05/2013 | US8389530 Substituted quinazoline compounds |
| 03/05/2013 | US8389518 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/05/2013 | US8389511 Bicyclic heterocyclic derivative |
| 03/05/2013 | US8389442 N-phenyl-′(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
| 03/05/2013 | CA2708324C Viral polymerase inhibitors |
| 03/05/2013 | CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/28/2013 | WO2013028639A1 C-halogen bond formation |
| 02/28/2013 | WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | WO2013027835A1 Method for producing optically active naphthalene compound |
| 02/28/2013 | WO2013027196A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | WO2013027001A1 Compounds and their use to treat histamine h3 related disorders |
| 02/28/2013 | WO2013027000A1 Pyridazinone compounds and their use as daao inhibitors |
| 02/28/2013 | WO2013026900A1 Pyridine derivatives as microbiocides |
| 02/28/2013 | WO2013026797A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 02/28/2013 | WO2013026587A1 1,4 disubstituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders |
| 02/28/2013 | WO2013026357A1 Preparation method of imidazole derivatives |
| 02/28/2013 | WO2013026264A1 Cb1 acceptor inhibitor compound with nitrogen-containing aromatic ring having hydroxyl and use thereof |
| 02/28/2013 | WO2013026163A1 Hepatitis c inhibitor compounds |
| 02/28/2013 | WO2012174312A3 Benzimidazole derivatives as antiviral agents |
| 02/28/2013 | WO2012149157A3 Heterocyclic compounds for the inhibition of pask |
| 02/28/2013 | WO2010150276A3 Process for preparing sulphoxide compounds |
| 02/28/2013 | WO2010128518A3 Novel process for the preparation of cisatracurium besylate |
| 02/28/2013 | US20130053563 Prodrug of triazolone compound |
| 02/28/2013 | US20130053561 Process for the preparation of substituted pyrimidine derivatives |
| 02/28/2013 | US20130053484 Sterically hindered amines |
| 02/28/2013 | US20130053419 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| 02/28/2013 | US20130053418 Acyclic organonitro compounds for use in treating cancer |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053403 Novel beta 3 adrenergic receptor agonists |
| 02/28/2013 | US20130053397 Indoles |
| 02/28/2013 | US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors |
| 02/28/2013 | US20130053385 Method of combating and controlling pests |
| 02/28/2013 | US20130053384 Certain Chemical Entities, Compositions, and Methods |
| 02/28/2013 | US20130053383 Indazoles |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053376 Novel tyrosine kinase inhibitors |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053362 Heterocyclic compounds and uses thereof |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053341 Therapeutic compounds and related methods of use |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130052281 Novel compounds |
| 02/28/2013 | US20130048975 Phenanthrocarbazole compound, and organic electroluminescent device using same |
| 02/28/2013 | US20130048956 Compound for electroluminescent device and organic electroluminescent devices using the same |
| 02/28/2013 | US20130048007 Novel cationic 4- aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 02/28/2013 | DE19964603B4 Sterisch gehinderte Aminether und deren Verwendung als Stabilisatoren für organisches Material Sterically hindered amine ethers and their use as stabilizers for organic material |
| 02/28/2013 | CA2846507A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | CA2846204A1 Pyridazinone compounds and their use as daao inhibitors |
| 02/28/2013 | CA2846183A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 02/28/2013 | CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |